newsfilter
← Latest News
GlobeNewswire·

Galecto to Participate in SVB Securities Global Biopharma Conference

BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company and a world leader in galectin biology focused on the development of novel treatments for fibrosis and